Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Edition
European
US
Neurology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Phase 2 Trial Results: TAK-071 Enhances Cognition in Parkinson’s Disease
January 2025
TAK-071 enhances cognition in Parkinson’s disease but doesn’t reduce gait variability, phase 2 trial results reveal.
Read more
21 Jan 2025
Phase 2 Trial Results: TAK-071 Enhances Cognition in Parkinson’s Disease
TAK-071 enhances cognition in Parkinson’s disease but doesn’t reduce gait variability, phase 2 trial results reveal.
20 Jan 2025
New Biomarker Links Brain Waste Clearance to Vascular Dementia
New biomarker links glymphatic dysfunction to vascular dementia, revealing pathways for prevention and treatment strategies.
17 Jan 2025
Gestational Hypertension and Preeclampsia Linked to Epilepsy and Migraine
Hypertensive pregnancy disorders increase the risk of migraines, epilepsy, and more neurological issues up to 15 years later.
16 Jan 2025
Ketamine Shows Promise for Parkinson’s Dyskinesia Treatment
Ketamine offers new hope for Parkinson’s dyskinesia by restoring motor cortex control and promoting long-term neural repair.
13 Jan 2025
What are the Early Symptoms of Paediatric Multiple Sclerosis?
Metabolic, sensory, and ocular symptoms may predict paediatric MS up to five years before diagnosis, study finds.
11 Jan 2025
Prenatal Tobacco Exposure Affects Brain Development in Children
Study links maternal tobacco use in pregnancy to long-term brain changes, urging preventive action for improved child health.
8 Jan 2025
AI Detects Parkinson’s with Near-Perfect Accuracy by Analysing Emotions
Groundbreaking study uses EEG and AI to diagnose Parkinson’s disease with near-perfect accuracy through emotional response analysis.
7 Jan 2025
Chronic Gut Virus Linked to Alzheimer’s Disease Development
Chronic gut infections from cytomegalovirus may contribute to Alzheimer’s, opening doors to antiviral treatment possibilities.
Loading posts...
1
2
3
…
33
Next »